| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.96▲ | 7.96▲ | 7.96▲ | 7.93▲ | 7.31▲ |
| MA10 | 7.82▲ | 7.72▲ | 7.72▲ | 7.50▲ | 7.33▲ |
| MA20 | 7.49▲ | 7.38▲ | 7.38▲ | 7.24▲ | 7.15▲ |
| MA50 | 7.23▲ | 7.22▲ | 7.23▲ | 7.21▲ | N/A |
| MA100 | 7.36▲ | 7.35▲ | 7.30▲ | 7.11▲ | N/A |
| MA200 | 7.25▲ | 7.13▲ | 7.13▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.054▲ | 0.086▲ | 0.086▲ | 0.126▲ | N/A |
| RSI | 67.572▲ | 67.530▲ | 67.325▲ | 67.915▲ | 53.367▲ |
| STOCH | 89.738▲ | 91.648▲ | 91.648▲ | 93.194▲ | 48.802 |
| WILL %R | -15.584▲ | -9.486▲ | -9.486▲ | -11.194▲ | -9.615▲ |
| CCI | 79.867 | 92.399 | 92.399 | 118.193▲ | 216.074▲ |
|
Saturday, August 15, 2026 11:12 PM
Kyntra Bio, Inc. ( KYNB) has disclosed a new risk, in the Share Price & Shareholder Rights category.
|
|
Tuesday, May 12, 2026 01:20 AM
Kyntra Bio, Inc. misses on earnings expectations. Reported EPS is $-3.76 EPS, expectations were $-3.36. Operator: Good day, and thank you for standing by. Welcome to the Kyntra Bio’s First Quarter ...
|
|
Tuesday, May 12, 2026 12:08 AM
Total Revenue: $3.7 million for Q1 2026, up from $2.7 million in Q1 2025. Total Operating Costs and Expenses: $17.6 million for Q1 2026, compared to $17.7 million in Q1 2025. R&D Expenses: $7.6 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/08/26 | 8.01 | 8.12 | 7.94 | 8.00 | 5,867 |
| 26/08/26 | 7.95 | 8.15 | 7.95 | 8.105 | 7,123 |
| 25/08/26 | 8.00 | 8.12 | 7.77 | 8.10 | 45,019 |
| 24/08/26 | 7.705 | 7.92 | 7.705 | 7.92 | 22,044 |
| 21/08/26 | 7.41 | 7.60 | 7.32 | 7.52 | 39,832 |
| 20/08/26 | 6.8729 | 7.39 | 6.8629 | 7.32 | 23,973 |
| 19/08/26 | 7.175 | 7.20 | 6.945 | 7.15 | 18,629 |
| 18/08/26 | 7.0662 | 7.2533 | 6.81 | 7.01 | 13,314 |
| 17/08/26 | 6.94 | 7.158 | 6.81 | 6.81 | 24,893 |
| 14/08/26 | 7.025 | 7.4074 | 6.9509 | 7.05 | 17,696 |
|
|
||||
|
|
||||
|
|